GB Sciences is formulating Cannabis-based therapies for specific clinical conditions based on an understanding of how cannabinoids interact with the natural receptors in the human body. By using insights gained into which cannabinoid and terpenoid compounds natively found in the Cannabis plant correspond to cannabinoid receptors involved in different disease-specific pathways, we can formulate targeted combinations of active ingredients for each condition.
Learn More
Which Conditions Are Treated by Cannabis-based Therapies?
Medical Cannabis has been indicated for some conditions such as glaucoma, AIDS wasting syndrome, multiple sclerosis, chemotherapy-induced nausea, and certain seizure disorders. While the effects of medical Cannabis on these indications have been well documented in the medical literature, most patients and their doctors have well-founded concerns regarding the consistency, safety, and efficacy of medical cannabis available at most standard dispensaries. Our approach is differentiated from standard practice in this field:
1.) We grow our medical cannabis in our proprietary GrowBLOX™ system to create harvest-to-harvest consistency in the levels of active cannabinoids in our proprietary strains.

2.) Our growing and curing system eliminate harmful pesticides and fungicides to ensure safety.

3.) Our consistent and safe cannabis products can be used in personalized therapies to increase efficacy.
Cannabis Works Through Our Body's Own Endocannabinoid System
The cannabinoids (KEYS) from the Cannabis plant are able to effect our body through our endocannabinoid system. The endocannabinoid system is composed of multiple cannabinoid receptors (LOCKS) that are functionally distributed in various tissues and organ systems. Reactions between cannabinoids and their corresponding cannabinoid receptors are known to control mood, appetite, memory, and pain-sensation (among other systems). The endocannabinoid system also includes the biochemical machinery for making our own internal cannabinoids "endocannabinoids". By using insights gained into which cannabinoids from the Cannabis plant correspond to cannabinoid receptors involved in different disease-specific pathways, we can formulate targeted combinations of active ingredients for each condition.
Three Sources of Cannabinoid Molecules
Cannabinoid molecules can be produced by three pathways: 1) phytocannabinoids are produced by the Cannabis plant, 2) endocannabinoids are created by humans and animals, and 3) synthetic cannabinoids have been produced artificially by pharmaceutical companies since the 1970's.
GB Sciences is formulating Cannabis-based therapies for specific clinical conditions based on an understanding of how cannabinoids interact with the natural receptors in the human body. By using insights gained into which cannabinoid and terpenoid compounds natively found in the Cannabis plant correspond to cannabinoid receptors involved in different disease-specific pathways, we can formulate targeted combinations of active ingredients for each condition.
Learn More
Which Conditions Are Treated by Cannabis-based Therapies?
Medical Cannabis has been indicated for some conditions such as glaucoma, AIDS wasting syndrome, multiple sclerosis, chemotherapy-induced nausea, and certain seizure disorders. While the effects of medical Cannabis on these indications have been well documented in the medical literature, most patients and their doctors have well-founded concerns regarding the consistency, safety, and efficacy of medical cannabis available at most standard dispensaries. Our approach is differentiated from standard practice in this field:
1.) We grow our medical cannabis in our proprietary GrowBLOX™ system to create harvest-to-harvest consistency in the levels of active cannabinoids in our proprietary strains.

2.) Our growing and curing system eliminate harmful pesticides and fungicides to ensure safety.

3.) Our consistent and safe cannabis products can be used in personalized therapies to increase efficacy.
Cannabis Works Through Our Body's Own Endocannabinoid System
The cannabinoids (KEYS) from the Cannabis plant are able to effect our body through our endocannabinoid system. The endocannabinoid system is composed of multiple cannabinoid receptors (LOCKS) that are functionally distributed in various tissues and organ systems. Reactions between cannabinoids and their corresponding cannabinoid receptors are known to control mood, appetite, memory, and pain-sensation (among other systems). The endocannabinoid system also includes the biochemical machinery for making our own internal cannabinoids "endocannabinoids". By using insights gained into which cannabinoids from the Cannabis plant correspond to cannabinoid receptors involved in different disease-specific pathways, we can formulate targeted combinations of active ingredients for each condition.
Cannabinoid Protection Of Barrier Tissues In Plants And Humans
Trichome structure. The trichome is a specialized structure that secretes a resinous, cannabinoid and terpene-containing substance onto the plant cuticle. This resin is protective – its production increases under conditions of wounding and elevated levels of UV damage.
Three Sources of Cannabinoid Molecules
Cannabinoid molecules can be produced by three pathways: 1) phytocannabinoids are produced by the Cannabis plant, 2) endocannabinoids are created by humans and animals, and 3) synthetic cannabinoids have been produced artificially by pharmaceutical companies since the 1970's.
Contact Us